J9225 Histrelin implant (vantas), 50 mg

Short descriptor: Vantas implant

✓ Active HCPCS Level II 2026
Open J9225 in the app →

Look up J9225 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J9225 is the HCPCS Level II code for Histrelin implant (vantas), 50 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2008-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
Histrelin implant
Dose / Unit
50 mg

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J9225 with the canonical source and edition:

J9225 — Histrelin implant (vantas), 50 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J9225

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J9225

Related Codes in Section J

← J9223 Inj. lurbinectedin, 0.1 mg J9226 → Supprelin la implant
J9218 Leuprolide acetate injeciton J9219 Leuprolide acetate implant J9220 Indigotindisulfonate sod 1mg J9223 Inj. lurbinectedin, 0.1 mg J9226 Supprelin la implant J9227 Inj. isatuximab-irfc 10 mg J9228 Ipilimumab injection J9229 Inj inotuzumab ozogam 0.1 mg J9230 Mechlorethamine hcl inj J9245 Inj melpha hydroch nos 50 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial